Monday, December 30, 2024
New Year, New You? If you're looking for medicated weight loss treatments this new year, we offer expert advice and rated-excellent customer service at Oxford Online Pharmacy
Have you struggled with your weight for years, found it difficult to lose weight or keep it off with exercise and diet alone? You might want to know more about weight loss injections to support your health goals.
With Mounjaro weight loss injections, you could lose over 22% of your starting body weight within a year.
Mounjaro contains the active ingredient Tirzepatide, a GLP-1 inhibitor, and works in 2 ways: making you feel fuller for longer and suppressing your appetite.
These injections can be used by people who are overweight or obese and have struggled to lose weight with exercise and diet alone.
This medicine comes in six different strength pens: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg. You gradually increase your dose monthly, which helps reduce unwanted Mounjaro side effects like nausea and constipation.
Learn more about the Mounjaro dosing schedule here.
Mounjaro is suitable for men and women over the age of 18.
When you order with Oxford Online Pharmacy, an independent UK-registered doctor will check your medical history, including your current medicines, to ensure this treatment option is safe for you.
To use these injections, you must have a BMI of over 30 or over 27 with certain weight-related health conditions.
Yes, these pens are available on the NHS, but you must meet specific requirements to receive this treatment.
In December 2024, NICE endorsed Mounjaro for weight loss treatment within the NHS in England and Wales, but only for people with a BMI of 35kg/m² or higher, particularly those with obesity-related health issues such as type 2 diabetes or those at significant risk for developing the condition.
January is always a popular time to look for new year Mounjaro deals. You will find many online pharmacies offering these weight loss injections. However, you should only buy from regulated, registered ones like Oxford Online Pharmacy.
When looking for a price comparison online, there are many options offered by different platforms, such as the Mumsnet weight loss feed. These Mounjaro Mumsnet prices are provided by the general public, who share their findings and experience with the medicine.
This information is helpful to those looking for more information about Mounjaro and other weight loss medicines and can be a great support when starting a weight loss journey.
However, anyone can add information to the feed, so be careful to ensure the information is correct when using these platforms.
Want to compare Mounjaro prices of regulated pharmacies? We’ve done it for you. Check out our Mounjaro price comparison UK here.
The price for these weight loss injections can vary depending on where you get them from.
When looking at different online pharmacies, you’ll notice that well-known companies like Boots and Asda sell Mounjaro for more than smaller suppliers.
Another thing to note is that subscription sites like Numan or Voy are not as cheap as they seem. Yes, they have a great introductory discount on their first pen; however, the price will jump for the remaining subscription.
At Oxford Online Pharmacy, keeping prices consistent is important to our customers, so we constantly check prices against our competitors to ensure we offer you both the best price and our outstanding customer service - call us to speak directly with our clinical team.
In addition to our low Mounjaro prices in the UK, we give you regular opportunities to save even more.
If you have found a price for the Mounjaro Kwikpen cheaper elsewhere online, Oxford Online Pharmacy (OOP) will match the price.
You can request a price match at OOP for any legitimate registered pharmacy also offering Mounjaro.
See our lowest price guarantee for more information and terms.
What is Mounjaro and how does it work?, Diabetes.org
Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen - Patient Information Leaflet (PIL) - (emc)
Mounjaro® (tirzepatide) Injection: The First and Only GIP and GLP-1 Receptor Agonist Approved for Type 2 Diabetes | Eli Lilly and Company